Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation.
Xiaotong JiangChangyu ShenCharlotte E TeunissenMark Hj WesselsHenrik ZetterbergGavin GiovannoniCarol M SinghBastien CabaColm ElliottElizabeth FisherCarl de MoorShibeshih BelachewArie R GafsonPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Without inflammatory activity, changes in sGFAP concentration in participants with SPMS were neither associated with current nor predictive of future disability progression.